trending Market Intelligence /marketintelligence/en/news-insights/trending/8yyHRIUGFU1nvedVDDgaQA2 content esgSubNav
In This List

Galmed Pharmaceuticals launches $35M offering of ordinary shares

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector


Galmed Pharmaceuticals launches $35M offering of ordinary shares

Galmed Pharmaceuticals Ltd. plans to sell up to $35.0 million of its ordinary shares in an at-the-market equity offering from time to time.

Stifel Nicolaus & Co. Inc. is acting as the sales agent for the offering.